Inventor
PASCOLO STEVE
DE24 patents
⚠️ This page may combine multiple inventors who share the name “PASCOLO STEVE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CUREVAC AG
9 patentsUS11135312B2Oct 5, 2021
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
CUREVAC AG35 citations97
US10568972B2Feb 25, 2020
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
CUREVAC AG35 citations97
US9655955B2May 23, 2017
Application of mRNA for use as a therapeutic against tumour diseases
CUREVAC AG42 citations97
US9463228B2Oct 11, 2016
Application of mRNA for use as a therapeutic against tumour diseases
CUREVAC AG28 citations97
US9439956B2Sep 13, 2016
Application of mRNA for use as a therapeutic against tumour diseases
CUREVAC AG29 citations97
US9433670B2Sep 6, 2016
Application of mRNA for use as a therapeutic against tumour diseases
CUREVAC AG29 citations97
US9433669B2Sep 6, 2016
Application of mRNA for use as a therapeutic against tumor diseases
CUREVAC AG29 citations97
US10017826B2Jul 10, 2018
Method for producing RNA
CUREVAC AG29 citations93
US11369691B2Jun 28, 2022
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
CUREVAC AG11 citations85
BIONTECH AG
3 patentsUS10980875B2Apr 20, 2021
Cytotoxic immunostimulating particles and uses thereof
BIONTECH AG2 citations73
US10172960B2Jan 8, 2019
Particles comprising single stranded RNA and double stranded RNA for immunomodulation
BIONTECH AG1 citations62
US10626400B2Apr 21, 2020
Stabilised formulations of RNA
BIONTECH AG0 citations52